INSIGHTS

INSIGHTS

Explore relevant life science news & events, helping drive industry research forward to improve human health.

Refine Insights By:

Will better characterization lead to safer biotherapeutics?
Podcasts

Will better characterization lead to safer biotherapeutics?

Academia, CROs, and industry must work together to create novel therapies with acceptable safety profiles.

How do CROs help virtual companies succeed in cell and gene therapies?
Podcasts

How do CROs help virtual companies succeed in cell and gene therapies?

Explore a key way to view the CRO dynamic, for virtual companies: The CRO as a part of a virtual company’s drug discovery team.

What is the value of working with a quality partner CRO?
Podcasts

What is the value of working with a quality partner CRO?

An honest discussion from the client perspective on gaining access to complex assays and services.

How can the field innovate for target-related issues in cell & gene therapies?
Podcasts

How can the field innovate for target-related issues in cell & gene therapies?

Experts explore how to adapt what already exists, and how to optimize, customize, and innovate to help clients meet their goals.

How can we take advantage of the FDA Modernization Act, and use non-animal models for safety testing?
Podcasts

How can we take advantage of the FDA Modernization Act, and use non-animal models for safety testing?

A lively discussion on growing scientific knowledge, technological development, and more sophisticated in vitro non-animal alternatives.

How do we create more predictive approaches to cell & gene therapies?
Podcasts

How do we create more predictive approaches to cell & gene therapies?

Experts say a variety of approaches that include the BioMAPÂŽ Platform, as well as continued innovation, are needed.